Skip to main content
padlock icon - secure page this page is secure

Free Content Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins

Download Article:
 Download
(PDF 423.6 kb)
 
SETTING: Mexico City, Mexico.

OBJECTIVE: To identify proteins synthetised by Mycobacterium tuberculosis in hypoxic culture, which resemble more closely a granuloma environment than aerobic culture, and to determine if they are recognised by antibodies from patients with active pulmonary tuberculosis (PTB).

DESIGN: Soluble extracts from M. tuberculosis H37Rv cultured under aerobic or hypoxic conditions were analysed using two-dimensional polyacrylamide gel electrophoresis, and proteins over-expressed under hypoxia were identified by mass spectrometry. The presence of immunoglobulin (Ig) G, IgA and IgM antibodies against these proteins was determined in the serum of 42 patients with active PTB and 42 healthy controls.

RESULTS: We selected three M. tuberculosis H37Rv proteins (alpha-crystallin protein [Acr, Rv2031c], universal stress protein Rv2623 and isocitrate lyase [ICL, RV0467]) that were over-expressed under hypoxia. Titres of anti-Acr and anti-ICL IgA antibodies were higher in patients than in healthy controls, with an area under the receiver operating characteristic curve of 0.71 for anti-ICL IgA antibodies.

CONCLUSION: ICL could be used in combination with other M. tuberculosis antigens to improve the sensitivity and specificity of current serological TB diagnostic methods.
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: 2D-PAGE/MS; hypoxia; serological diagnostic methods

Document Type: Research Article

Affiliations: 1: Departamento de Inmunología, Escuela Nacional de Ciencias Bioló gicas, Instituto Politécnico Nacional (IPN), Mexico City, Mexico; Programa de Posgrado en Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico City, Mexico 2: Departamento de Microbiología, Programa de Posgrado en Biomedicina y Biotecnología Molecular, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico City, Mexico 3: Centro de Investigaciones Regionales ‘Dr Hideyo Noguchi', Universidad Autónoma de Yucatán, Yucatán, Mexico 4: Servicio de Neumología, Hospital General de México ‘Dr Eduardo Liceaga', Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Secretaría de Salud, Mexico City, Mexico 5: Departamento de Inmunología, Instituto de Investigaciones Biomédicas, UNAM, Mexico City, Mexico 6: Isidro Espinosa de los Reyes Instituto Nacional de Perinatología, Mexico City, Mexico 7: Departamento de Microbiología, Escuela Nacional de Ciencias Bioló gicas, Instituto Politécnico Nacional (IPN), Mexico City, Mexico 8: Departamento de Inmunología, Escuela Superior de Medicina, IPN, Mexico City, Mexico 9: Departamento de Inmunología, Escuela Nacional de Ciencias Bioló gicas, Instituto Politécnico Nacional (IPN), Mexico City, Mexico

Publication date: December 1, 2016

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more